Literature DB >> 31284854

Mitochondrial Injury and Targeted Intervention in Septic Cardiomyopathy.

Ying Tan1,2, Sainan Chen1,2, Jiankai Zhong3, Jun Ren2,4, Maolong Dong1,5.   

Abstract

BACKGROUND: Sepsis and septic shock are known to prompt multiple organ failure including cardiac contractile dysfunction, which is typically referred to as septic cardiomyopathy. Among various theories postulated for the etiology of septic cardiomyopathy, mitochondrial injury (both morphology and function) in the heart is perceived as the main culprit for reduced myocardial performance and ultimately heart failure in the face of sepsis.
METHODS: Over the past decades, ample of experimental and clinical work have appeared, focusing on myocardial mitochondrial changes and related interventions in septic cardiomyopathy. RESULTS AND
CONCLUSION: Here we will briefly summarize the recent experimental and clinical progress on myocardial mitochondrial morphology and function in sepsis, and discuss possible underlying mechanisms, as well as the contemporary interventional options. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Mitochondria; contraction; heart; heart failure; intervention; sepsis.

Mesh:

Year:  2019        PMID: 31284854     DOI: 10.2174/1381612825666190708155400

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  8 in total

Review 1.  FUN14 Domain Containing 1 (FUNDC1): A Promising Mitophagy Receptor Regulating Mitochondrial Homeostasis in Cardiovascular Diseases.

Authors:  Yu Mao; Jun Ren; Lifang Yang
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

2.  CD74 knockout protects against LPS-induced myocardial contractile dysfunction through AMPK-Skp2-SUV39H1-mediated demethylation of BCLB.

Authors:  Yuanfei Luo; Congcong Fan; Mingjie Yang; Maolong Dong; Richard Bucala; Zhaohui Pei; Yingmei Zhang; Jun Ren
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

3.  Inhibition of miR‑101‑3p protects against sepsis‑induced myocardial injury by inhibiting MAPK and NF‑κB pathway activation via the upregulation of DUSP1.

Authors:  Ye Xin; Li Tang; Jing Chen; Dong Chen; Wen Wen; Fugang Han
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

4.  Enhanced Bioavailability of Boswellic Acid by Piper longum: A Computational and Pharmacokinetic Study.

Authors:  K Reeta Vijayarani; Manoj Govindarajulu; Sindhu Ramesh; Mansour Alturki; Mohammed Majrashi; Ayaka Fujihashi; Mohammed Almaghrabi; N Kirubakaran; Jun Ren; R Jayachandra Babu; Forrest Smith; Timothy Moore; Muralikrishnan Dhanasekaran
Journal:  Front Pharmacol       Date:  2020-12-15       Impact factor: 5.810

5.  CircTLK1 modulates sepsis-induced cardiomyocyte apoptosis via enhancing PARP1/HMGB1 axis-mediated mitochondrial DNA damage by sponging miR-17-5p.

Authors:  Yu Qiu; Ying Yu; Xiao-Mei Qin; Tao Jiang; Yan-Fang Tan; Wen-Xian Ouyang; Zheng-Hui Xiao; Shuang-Jie Li
Journal:  J Cell Mol Med       Date:  2021-08-19       Impact factor: 5.310

Review 6.  Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis.

Authors:  Chuqiao Wang; Guorui Liang; Jieni Shen; Haifan Kong; Donghong Wu; Jinxiang Huang; Xuefeng Li
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

Review 7.  Mitochondrial Quality Control in the Maintenance of Cardiovascular Homeostasis: The Roles and Interregulation of UPS, Mitochondrial Dynamics and Mitophagy.

Authors:  Yujie Song; Yuerong Xu; Yingying Liu; Jie Gao; Lele Feng; Yuxi Zhang; Lei Shi; Miao Zhang; Dong Guo; Bingchao Qi; Mingming Zhang
Journal:  Oxid Med Cell Longev       Date:  2021-11-11       Impact factor: 6.543

Review 8.  Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.

Authors:  Huan Lin; Wenting Wang; Madeline Lee; Qinghe Meng; Hongsheng Ren
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.